慢性腎臟病與心臟血管疾病

李宗倫 ； 林志慶

《臨床醫學月刊》 83卷4期 (2019/04) Pp. 218-223

https://doi.org/10.6666/ClinMed.201904_83(4).0036

摘要

心臟血管疾病為慢性腎臟病之重要供病症。現今臨床指引在預測心臟血管疾病相關危險因子無法得到統一的共識。一些大型次分析研究發現慢性腎臟病患者之eGFR與尿蛋白與心臟血管疾病有相關性。其他研究也指出血液中肌酐酸，cystatin C和β2-macroglobulin可以增加此類型患者之心臟血管疾病之預測率。近年來冠狀動脈鈣離子分數和高敏感性Troponin T在預測慢性腎臟病患者之心臟血管危險因子也愈來愈被重視。本文將介紹近年來針對腎臟病患者之心臟血管危險因子傳統及非傳統預測因子檢查之研究整理。

關鍵字

尿蛋白 ； 心臟血管疾病 ； 危險因子

參考文獻

1. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013;382:339-52.

2. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013ACC/AHA guide line on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S49-73.

3. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Areport of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:2889-934.

4.Piepoli MF, Hoes AW, Agewall S, et al. 2016European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice(constituted by representatives of 10societiesandbyinvitedexperts). Developed with the special contribution of the European Association for Cardio- vascular Prevention & Rehabilitation(EACPR). Eur Heart J 2016;37:2315-81.

6. Inker LA, Levey AS. Pro : estimating GFR using the chronic kidney disease epidemiology collaboration(CKD-EPI)2009 creatinine equation: the time for change is now. Nephrol Dial Transplant 2013;28:1390-6.